Industry Insights

41. Sustainability Considerations For Drug Delivery Device End-To-End Solutions 6/15/2022

    Learn how to address the gradual unlinking of economic activity from the consumption of finite resources and the removal of waste to support and help prevent a global climate catastrophe.

42. Improving Swallowing And Palatability With Patient‑Friendly Forms 1/15/2026

    Improve medication adherence and health outcomes by developing patient-friendly dosage forms that enhance swallowability and palatability for pediatric, geriatric, and dysphagic populations.

43. Screening T7 Polymerases To Optimize xRNA Yield And Quality 10/31/2025

    Discover how the evolution of T7 polymerase is optimizing in vitro transcription for RNA therapeutics. Learn to balance performance, cost, and supply to make smart choices for your xRNA manufacturing.

44. Mitigating Risk In IND And Drug Product Development 1/22/2026

    Early CMC planning, a focus on manufacturability, and timely data generation help drug candidates cross the Valley of Death by reducing regulatory risk and easing clinical transition.

45. Managing Contamination Risks In The Pharmaceutical And Medical Device Industries Using Relational Risk Analysis 2/18/2025

    Of all the risks associated with pharmaceuticals and medical devices, controlling contamination is one of the most important and difficult challenges. Relational risk analysis (ReRA) can help.

46. The Clinical Landscape Of ADCs In 2023: Diverse Technologies, Narrow Target 3/16/2023

    Antibody-drug conjugates (ADCs) are a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the potency of cytotoxic drugs. This article shares data surrounding the ADCs currently entering clinical trials, a look at failed ADC programs, and more.

47. Genomic Medicine Demands Manufacturing Innovation 5/28/2024

    The promise of novel therapeutic modalities can only be realized when effective science is paired with efficient manufacturing to provide cost-effective therapies to patients in need.

48. Apollo, A Unique Cloud-Based Platform, Takes Flight At Charles River 8/14/2023

    The leading-edge system breaking new ground in the contract research space offers real-time access to study data and empowers users with self-serve access to analyze their important data.

49. The Importance Of A Quality Management System 4/15/2021

    In the pharmaceutical industry, having a good quality management system is extremely important. This involves set processes to ensure that products continuously meet industry standards.

50. Regulatory, Legislative Actions Set The Tone For Biosimilars In 2021 3/8/2021

    This article focuses on regulatory and legislative actions in 2020 that may impact the burgeoning biosimilars space in 2021 and beyond. In particular, the authors revisit the implications of the March 23, 2020 transition date, as well as FDA’s efforts to address biosimilar competition, interchangeability, and the COVID-19 pandemic.